| FDG PET of the Thymus DOWNLOAD FACT SHEET IN PDF References: 1) Rosenbaum SJ, Lind T, Antoch G. False-Positive FDG PET Uptake – the Role of PET/CT. Eur Radiol 2006;16:1054-1065 [PDF] 2) Paes FM, Kalkanis DG, Sideras PA. FDG PET/CT of Extranodal Involvement in Non-Hodgkin Lymphoma and Hodgkin Disease. Radiographics 2010;30:269-291 [PDF] 3) Shammas A, Lim R, Charron M. Pediatric FDG PET/CT: Physiologic Uptake, Normal Variants, and Benign Conditions. Radiographics 2009;29:1467-1486 [PDF] 4) Liu Y, Ghesani NV, Zuckier LS. Physiology and Pathophysiology of Incidental Findings Detected on FDG-PET Scintigraphy. Semin Nucl Med 2010;40:294-315 [PDF] 5) Wittram C, Fischman AJ, Mark E. Thymic Enlargement and FDG Uptake in Three Patients: CT and FDG Positron Emission Tomography Correlated with Pathology. AJR 2003;180:519-522 [PDF] 6) Ferdinand B, Gupta P, Kramer EL. Spectrum of Thymic Uptake at 18F-FDG PET. Radiographics 2004;24:1611-1616 [PDF] 7) Nakahara T, Fujii H, Ide M. FDG uptake in the morphologically normal thymus: comparison of FDG positron emission tomography and CT. The British Journal of Radiology 2001;74:821-824 [PDF] 8) Zhen Z, Sun X, Xia Y. Clinical Analysis of Thymic Regrowth Following Chemotherapy in Children amd Adolescents with Malignant Lymphoma. Jpn C Clin Oncol 2010;40(12):1128-1134 [PDF] 9) Brink I, Reinhardt MJ, Hoegerle S. Increased Metabolic Activity in the Thymus Gland Studied with 18F-FDG PET: Age Dependency and Frequency after Chemotherapy. J Nucl Med 2001;42: 591-595 [PDF] 10) Liu Y. Characterization of thymic lesions with F-18 FDG PET-CT: an emphasis on epithelial tumors. Nucl Med Commun 2011;32:554-562 [PDF] 11) Liu RS, Yeh SH, Huang MH. Use of fluorine-18 fluorodeoxyglucose positrom emission tomography in the detection of thymoma: a preliminary report. Eur J Nucl Med 1995;22:1402- 1407 [PDF] 12) Sung YM, Lee KS, Kim BT. 18F-FDG PET/CT of Thymic Epithelial Tumors: Usefulness for Distinguishing and Staging Tumor Subgroups. J Nucl Med 2006;47:1628-1634 [PDF] 13) Endo M, Nakagawa K, Ohde Y. Utility of 18F-FDG-PET for differentiating the grade of malignancy in thymic epithelial tumors. Lung Cancer 2008;61:350-355 [PDF] 14) Igai H, Matsuura N, Tarumi S. Usefulness of [18F]fluoro-2-deoxy-D-glucose positron emission tomography for predicting World Health Organization malignancy grade of thymic epithelial tumors. Eur J Cardiothorac Surg 2011;40:143-145 [PDF] 15) Inoue A, Tomiyama N, Tatsumi M. 18F-FDG PET for the evaluation of thymic epithelial tumors: Correlation with the World Health Organization classification in addition to dual-time-point imaging. Eur J Nucl Med Mol Imaging 2009;36:1219-1225 [PDF] 16) Travaini LL, Petralia G, Trifiro G. [18F]FDG positron emission tomography/computed tomography and multidetector computed tomography roles in thymic lesion treatment planning. Lung Cancer 2008;61:362-268 [PDF] 17) El-Bawab H, Al-Sugair AA, Rafay M. Role of fluorine-18 fluorodeoxyglucose positron emission tomography in thymic pathology. European Journal of Cardio-thoracic Surgery 2007; 31:731-736 [PDF] 18) Luzzi L, Campione A, Gorla A. Role of fluorine-fluorodeoxyglucose positron emission tomography/computed tomography in preoperative assessment of anterior mediastinal masses. Eur J Cardiothorac Surg 2009;36:475-479 [PDF] 19) Jerushalmi J, Frenkel A, Bar-Shalom R. Physiologic Thymic Uptake of 18F-FDG in Children and Young Adults: A PET/CT Evaluation of Incidence, Patterns, and Relationship to Treatment. J Nucl Med 2009;50:849-853 [PDF] 20) Shibata H, Nomori H, Uno K. 18F-Fluorodeoxyglucose and 11C-Acetate Positron Emission Tomography Are Useful Modalities for Diagnosing the Histologic Type of Thymoma. Cancer 2009;115:2531-2538 [PDF] 21) Sasaki M, Kuwabara Y, Ichiya Y. Differential Diagnosis of Thymic Tumors Using a Combination of 11C-Methionine PET and FDG PET. J Nucl Med 1999;40:1595-1601 [PDF] 22) Kumar A, Regmi SK, Dutta R. Characterization of thymic masses using 18F-FDG PET-CT. Ann Nucl Med 2009;23:569-577 [PDF] 23) Alibazoglu H, Alibazoglu B, Hollinger E. Normal Thymic Uptake of 2-Deoxy-2[F-18]fluoro-D- Glucose. Clinical Nuclear Medicine 1999;24(8):597-600 [PDF] 24) Patel P. Alibazoglu H, Amjad A. Normal Thymic Uptake of FDG on PET Imaging. Clinical Nuclear Medicine 1996;21(10):772-775 [PDF] 25) Gawande RS, Khurana A, Messing S. Differentiation of Normal Thymus from Anterior Mediastinal Lymphoma and Lymphoma Recurrence at Pediatric PET/CT. Radiology 2012;262(2): 613-622 [PDF] |